Biofeedback for Dysfunctional Voiding and Giggle Incontinence
1 other identifier
observational
60
1 country
1
Brief Summary
This study aims to evaluate the efficacy of biofeedback treatment for dysfunctional voiding and giggle incontinence in children. Predictive factors of treatment success will also researched.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2022
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2022
CompletedFirst Submitted
Initial submission to the registry
November 25, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedFirst Posted
Study publicly available on registry
December 8, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2026
CompletedDecember 8, 2025
November 1, 2025
3.3 years
November 25, 2025
November 25, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of Participants with Biofeedback-Related Resolution
Participants achieved a complete response which means 100% improvement in resolution of incontinence and abnormal voiding pattern
From enrollment to the end of treatment at 18 weeks
Other Outcomes (1)
Predictive Factors of Treatment Response
18 weeks
Study Arms (2)
Giggle incontinence
Patients who received biofeedback therapy for giggle incontinence
Dysfunctional voiding
Patients who received biofeedback therapy for dysfunctional voiding
Interventions
Biofeedback therapy is a behavioral treatment method that helps patients become more aware of and gain better control over their pelvic floor muscles. Using EMG electrodes, muscle activity is monitored and presented to the patient visually or audibly, enabling them to recognize and correct improper muscle contractions or relaxations that contribute to urinary incontinence.
Eligibility Criteria
Patients who were received biofeedback therapy for dysfunctional voiding and giggle incontinece in pediatric urology clinic of Sancaktepe Sehit Prof Dr Ilhan Varank Training and Research Hospital
You may qualify if:
- Patients diagnosed with dysfunctional voiding or giggle incontinence
- Patients treated with biofeedback therapy
You may not qualify if:
- Presence of anatomical or neurological problems
- Patients with missing data
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sancaktepe Sehit Prof dr Ilhan Varank Training and Research Hospital
Istanbul, Kadikoy, 34000, Turkey (Türkiye)
Related Publications (2)
Sadeghi M, Oskouie IM, Naserghandi A, Arvin A, Majidi Zolbin M. Exploring dysfunctional voiding in girls: a comprehensive literature review of assessment and management strategies. BMC Urol. 2025 Apr 12;25(1):87. doi: 10.1186/s12894-025-01772-0.
PMID: 40221717BACKGROUNDGonzalez-Maldonado AA, Garcia-Merida M. Giggle incontinence: a scoping review. Pediatr Res. 2024 Jun;95(7):1720-1725. doi: 10.1038/s41390-024-03065-y. Epub 2024 Feb 2.
PMID: 38307925BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical doctor
Study Record Dates
First Submitted
November 25, 2025
First Posted
December 8, 2025
Study Start
September 1, 2022
Primary Completion
December 1, 2025
Study Completion
April 1, 2026
Last Updated
December 8, 2025
Record last verified: 2025-11